Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Completed · Not applicable · Has a placebo group
Conditions studied: Obesity, Schizophrenia, Schizoaffective Disorder
In brief
The purpose of this clinical trial is to find out how effective low dose oral naltrexone is on reducing body weight when compared to placebo in women with schizophrenia and schizoaffective disorder.
Key facts
- Study ID
- NCT00793780
- Run by
- Yale University
- People needed
- 24
- Starts
- 2008-12-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2016-10-06
Who can join
Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women between the ages of 18 to 70
- Meet DSM-IV (Diagnostic and Statistical Manual version IV) criteria for schizophrenia or schizoaffective disorder based on SCID (Structured Clinical Interview for the DSM-IV) interview
- Overweight, as defined with a BMI of equal to or greater than 27 kg/m² and continuing weight gain in the past year above 2% of previous years total body weight
- Be on a stable dose of antipsychotic medication; i.e. at least one month with no dosage change, and two months from an antipsychotic switch; 5) Deemed to be symptomatically stable by the clinical staff in the last two months
You may not qualify if…
- Meet criteria for current alcohol or other substance dependence, opioid use for any reason or positive urine drug screen for opiates
- A history of dementia, mental retardation or other neurological disorder that may interfere with study ratings
- Not capable of giving informed consent for participation in this study
- Ongoing pregnancy
- Known sensitivity to naltrexone
- A medical disorder that is known to cause obesity
- Use of sibutramine, topiramate, amphetamines or over the counter weight remedies
- Impaired liver functions (greater than 3 times the upper limit of normal)
- Diagnosed with polycystic ovary syndrome
- Currently being treated with insulin
- Current use of Depo-Provera or any natural/synthetic hormone treatment known to cause significant weight gain
Where it is running
- Connecticut Mental Health Center — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.